Jane Street’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208K Buy
+15,100
New +$228K ﹤0.01% 10055
2025
Q4
Sell
-26,600
Closed -$493K 11244
2025
Q3
$493K Buy
+26,600
New +$418K ﹤0.01% 7891
2025
Q1
Sell
-23,600
Closed -$520K 9548
2024
Q4
$520K Sell
23,600
-17,200
-42% -$331K ﹤0.01% 6701
2024
Q3
$687K Buy
+40,800
New +$605K ﹤0.01% 6624

Other funds holding CLBT

Jane Street's CLBT Position: Q1 2026 in Review

Jane Street increased its Cellebrite (CLBT) stake by 198% in Q1 2026, buying an estimated $7.16M and bringing the position to 714,514 shares worth $9.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Jane Street first reported a position in CLBT in Q1 2024 and has held it in 7 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Jane Street held 714,514 shares of Cellebrite worth $9.85M as of Q1 2026.
  • Jane Street bought 474,991 Cellebrite shares in Q1 2026, an estimated $7.16M.
  • Cellebrite made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2562 holding.
  • Jane Street first reported a position in Cellebrite in Q1 2024 and has held it in 7 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.